Matches in Wikidata for { <http://www.wikidata.org/entity/Q98185764> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q98185764 description "2020 ജൂലൈ 29-ന് പ്രസിദ്ധീകരിച്ച ശാസ്ത്രീയ ലേഖനം" @default.
- Q98185764 description "artículu científicu espublizáu en xunetu de 2020" @default.
- Q98185764 description "scientific article published on 29 July 2020" @default.
- Q98185764 description "wetenschappelijk artikel" @default.
- Q98185764 description "наукова стаття, опублікована 29 липня 2020" @default.
- Q98185764 name "Prediction of Improved Therapeutics for Fabry Disease Patients Generated by Mutagenesis of the á-Galactosidase A Active Site, Dimer Interface, and Glycosylation Region" @default.
- Q98185764 name "Prediction of Improved Therapeutics for Fabry Disease Patients Generated by Mutagenesis of the á-Galactosidase A Active Site, Dimer Interface, and Glycosylation Region" @default.
- Q98185764 type Item @default.
- Q98185764 label "Prediction of Improved Therapeutics for Fabry Disease Patients Generated by Mutagenesis of the á-Galactosidase A Active Site, Dimer Interface, and Glycosylation Region" @default.
- Q98185764 label "Prediction of Improved Therapeutics for Fabry Disease Patients Generated by Mutagenesis of the á-Galactosidase A Active Site, Dimer Interface, and Glycosylation Region" @default.
- Q98185764 prefLabel "Prediction of Improved Therapeutics for Fabry Disease Patients Generated by Mutagenesis of the á-Galactosidase A Active Site, Dimer Interface, and Glycosylation Region" @default.
- Q98185764 prefLabel "Prediction of Improved Therapeutics for Fabry Disease Patients Generated by Mutagenesis of the á-Galactosidase A Active Site, Dimer Interface, and Glycosylation Region" @default.
- Q98185764 P1433 Q98185764-3F8C8E8A-E5A4-4DA6-AAD1-49BA610640FB @default.
- Q98185764 P1476 Q98185764-97BFA0F8-9612-483A-A34D-E41BD8488B48 @default.
- Q98185764 P2093 Q98185764-5B4F62AF-0884-49A7-AF50-B6FAFEC92DE6 @default.
- Q98185764 P2093 Q98185764-941517C4-ABEA-406D-BA3A-8B0E71E88406 @default.
- Q98185764 P2093 Q98185764-AE85C417-1ED6-4B3B-8B9A-F6D94C08838A @default.
- Q98185764 P304 Q98185764-5408C0B7-89CF-4F3B-9897-C69DDAFC3539 @default.
- Q98185764 P31 Q98185764-BA139F02-2DB0-4CC2-9AA9-7DC6F4A7FFCC @default.
- Q98185764 P356 Q98185764-F4A94E8A-4519-4CE3-B119-F8737EF49047 @default.
- Q98185764 P577 Q98185764-E8B71275-7544-4C83-884C-9D3D185ACE7D @default.
- Q98185764 P698 Q98185764-23BB45E6-B5FC-4623-9622-732D79A888BD @default.
- Q98185764 P921 Q98185764-B4903205-09EC-4CDD-962C-A7BB20861CEB @default.
- Q98185764 P356 J.PEP.2020.105710 @default.
- Q98185764 P698 32738442 @default.
- Q98185764 P1433 Q7251430 @default.
- Q98185764 P1476 "Prediction of Improved Therapeutics for Fabry Disease Patients Generated by Mutagenesis of the á-Galactosidase A Active Site, Dimer Interface, and Glycosylation Region" @default.
- Q98185764 P2093 "David H Calhoun" @default.
- Q98185764 P2093 "Erin S Stokes" @default.
- Q98185764 P2093 "M Lane Gilchrist" @default.
- Q98185764 P304 "105710" @default.
- Q98185764 P31 Q13442814 @default.
- Q98185764 P356 "10.1016/J.PEP.2020.105710" @default.
- Q98185764 P577 "2020-07-29T00:00:00Z" @default.
- Q98185764 P698 "32738442" @default.
- Q98185764 P921 Q615645 @default.